Global Stent Market 2016: is estimated generate a revenue of $16,666 million by 2022


The world stent market is estimated tgenerate a revenue of $16,666 million by 2022. The growth in the world stents market is primarily attributed tthe rising geriatric population, whare more susceptible tstrokes and require a stent implant for treatment, technological advancements in stents, increased adoption rate of these devices, and increased risk of restenosis in patients undergoing angioplasty. In addition, unhealthy diet habits and lack of necessary physical activity lead tthe development of cardiovascular diseases, and hence increase the need for percutaneous coronary interventions. Conversely, stringent government regulations for the approval of stents as they are highly specific devices and high cost of stent implant procedures are factors restraining the market growth.

Key players operating in the world stents market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS SA, and TerumCorporation.

Access Full Report With TOC @

The report segments the world stents market based on product type, material, and geography. Based on product type, it is categorized intcoronary stents and peripheral/vascular stents. Mainly three types of coronary stents are used, namely, drug-eluting stents, bare metal stents, and bioabsorbable stents. Out of these, endothelial progenitor cell capture stent, a type of drug-eluting stent, is preferred over the others as it uses the latest technology and prevents stent thrombosis. Coronary stents was the highest revenue-generating and fastest growing segment in 2015, registering a CAGR of 9.5% during the analysis period, owing tincreasing advances in the field of interventional cardiology coupled with the progress of minimally invasive techniques.

Based on material, the market is segmented intmetallic biomaterials, polymer biomaterials, and natural biomaterials. Among these, metallic stents segment generated the highest revenue in 2015 and natural biomaterials segment is estimated tgrow at fastest CAGR of 10.5% from 2016-2022.

Based on geography, the market is divided intNorth America, Europe, Asia-Pacific, and LAMEA regions. Asia-Pacific is expected tcontinue tdominate due trise in the geriatric population, favorable reimbursement rates, and rise in the prevalence of chronic disorders even among younger population. LAMEA is expected temerge as the area with maximum growth potential, owing tthe presence of high unmet medical needs and constantly improving healthcare infrastructure tcure cardiac disorders, hemodialysis, and other clinical conditions which lead tconstriction of blood vessels. Huge investments in developing nations by key players results in market growth owing tthe rapidly growing aged population.

Inquiry For Buying This Premium Report @

A stent is a metallic or a polymer tube implanted intthe lumen of any blood vessel or a duct in order tkeep the passage open. A variety of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus tallow the passage of food and beverages in patients suffering from esophageal cancer. They are alsinserted in the ureter tprevent obstruction of urine flow from kidney, in the gall bladder tallow passage of bile in patients suffering from gall bladder cancer, and in the abdomen & gastrointestinal tract. They are generally made of metals, polymers, and natural bioabsorbable materials.

Table Of Content Of This Report :


1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models


2.1 CXO perspective


3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]

About Nicole Austin

This is Nicole Austin is Assistant Manager and senior principal of the Market Research Store, a market research firm located in Florida, New York. I am Post Graduated of University of Miami, where I received MBA in Research and Development Management. I started Market Research and Analysis from a young age and most of my skills and knowledge are self taught. Find me on Google, Linkedin,Facebook

View all posts by Nicole Austin →

Leave a Reply

Your email address will not be published. Required fields are marked *